The biotech is now banking on secondary data signals as it progresses ignaseclant to late-stage trials in Charcot-Marie-Tooth disease.
Queen Elizabeth University Hospital in Glasgow becomes Scotland’s first CMTA Centre of Excellence for Charcot-Marie-Tooth ...